Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:50 am Purchase | 2025-12-21 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 4,434,773 9.990% | 1,121,069 (+33.83%) | Filing History |
| 2025-08-15 08:00 am Sale | 2025-06-30 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 3,313,704 9.990% | -2,626,250 (-44.21%) | Filing History |
| 2025-05-15 10:15 am Purchase | 2025-03-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 5,939,954 9.990% | 5,838,871 (+5776.31%) | Filing History |
| 2025-02-26 09:16 am Purchase | 2025-02-17 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 101,083 9.990% | 96,306 (+2016.04%) | Filing History |
| 2025-02-13 1:44 pm Sale | 2024-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Ayrton Capital LLC | 26,305 6.200% | -611 (-2.27%) | Filing History |
| 2024-11-14 5:17 pm Purchase | 2024-09-30 | 13G | PETROS PHARMACEUTICALS INC PTPI | Ayrton Capital LLC | 26,916 6.500% | 17,144 (+175.44%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 20,182 4.990% | 13,991 (+225.99%) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Ayrton Capital LLC | 9,772 9.900% | 9,772 (New Position) | Filing History |
| 2024-02-06 10:23 am Sale | 2023-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 6,191 6.600% | -495 (-7.40%) | Filing History |
| 2023-02-08 06:08 am Purchase | 2022-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 6,686 7.600% | 279 (+4.35%) | Filing History |
| 2022-02-28 4:30 pm Purchase | 2021-12-02 | 13D | PETROS PHARMACEUTICALS INC PTPI | SHULMAN JOHN D | 31,524 34.470% | 4,546 (+16.85%) | Filing History |
| 2022-02-23 4:25 pm Purchase | 2021-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 4,777 4.990% | 1,880 (+64.89%) | Filing History |
| 2022-02-11 07:54 am Purchase | 2021-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 6,407 7.200% | 4,091 (+176.64%) | Filing History |
| 2022-02-10 2:46 pm Sale | 2021-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | HAYWOOD GEORGE WEAVER | 180 0.200% | -3,885 (-95.57%) | Filing History |
| 2021-10-27 09:47 am Purchase | 2021-10-19 | 13G | PETROS PHARMACEUTICALS INC PTPI | HAYWOOD GEORGE WEAVER | 4,065 7.600% | 4,065 (New Position) | Filing History |
| 2021-10-22 06:51 am Purchase | 2021-10-18 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 2,897 9.990% | 2,897 (New Position) | Filing History |
| 2021-10-20 5:25 pm Purchase | 2021-10-18 | 13D | PETROS PHARMACEUTICALS INC PTPI | SHULMAN JOHN D | 26,978 51.190% | 13,394 (+98.60%) | Filing History |